You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

13 Results
Guidelines and Advice
Status: In-Review
ID: GL 2-26
Version: 3
Aug 2022
Guidelines and Advice
Status: In-Review
ID: 4-8
Version: 4
Jul 2019
Guidelines and Advice
Status: Current
ID: 7-11
Version: 3
Mar 2022
Guidelines and Advice
Status: Current
ID: SCT-2
Version: 2
Nov 2019
Guidelines and Advice
Status: Current
ID: GL 16-3
Version: 3
Mar 2022
Guidelines and Advice
Status: Current
ID: 5-11
Version: 2
Jan 2022
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Drugs Used:
SORAfenib (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2019
Cancer facts
Jun 2019
Guidelines and Advice
Status: Current
Version: 2
Mar 2022
Guidelines and Advice
Status: Current
Version: 2
Mar 2022
Guidelines and Advice
Status: Current
Sep 2019
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
sotorasib (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Feb 2022

Pages